Stay updated on Psilocybin for OCD Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for OCD Clinical Trial page.

Latest updates to the Psilocybin for OCD Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to reflect a new version of the study on psilocybin for treating obsessive-compulsive disorder (OCD), with significant changes in the study's design and details about the administration of the drug. Notably, the principal investigator's name has been added, and the previous description of the study's purpose has been removed.SummaryDifference28%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Psilocybin for OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for OCD Clinical Trial page.